Spyre Therapeutics, Inc. (SYRE)
90.33
-2.00
(-2.17%)
USD |
NASDAQ |
Oct 23, 16:00
90.36
+0.03
(+0.03%)
Pre-Market: 20:00
Spyre Therapeutics Market Cap : 7.955B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 7.955B |
| October 22, 2026 | 8.131B |
| October 21, 2026 | 8.186B |
| October 20, 2026 | 8.049B |
| October 19, 2026 | 7.461B |
| October 16, 2026 | 7.036B |
| October 15, 2026 | 7.054B |
| October 14, 2026 | 6.924B |
| October 13, 2026 | 7.085B |
| October 12, 2026 | 7.565B |
| October 09, 2026 | 7.546B |
| October 08, 2026 | 7.036B |
| October 07, 2026 | 7.120B |
| October 06, 2026 | 7.055B |
| October 05, 2026 | 8.165B |
| October 02, 2026 | 8.207B |
| October 01, 2026 | 7.920B |
| September 30, 2026 | 7.840B |
| September 29, 2026 | 7.461B |
| September 28, 2026 | 7.555B |
| September 25, 2026 | 7.546B |
| September 24, 2026 | 7.670B |
| September 23, 2026 | 7.765B |
| September 22, 2026 | 8.099B |
| September 21, 2026 | 8.105B |
| Date | Value |
|---|---|
| September 18, 2026 | 7.948B |
| September 17, 2026 | 8.162B |
| September 16, 2026 | 8.029B |
| September 15, 2026 | 8.009B |
| September 14, 2026 | 7.996B |
| September 11, 2026 | 7.979B |
| September 10, 2026 | 7.812B |
| September 09, 2026 | 7.655B |
| September 08, 2026 | 7.995B |
| September 04, 2026 | 7.836B |
| September 03, 2026 | 7.684B |
| September 02, 2026 | 7.666B |
| September 01, 2026 | 7.794B |
| August 31, 2026 | 7.867B |
| August 28, 2026 | 7.957B |
| August 27, 2026 | 8.244B |
| August 26, 2026 | 8.243B |
| August 25, 2026 | 9.455B |
| August 24, 2026 | 9.392B |
| August 21, 2026 | 9.378B |
| August 20, 2026 | 9.492B |
| August 19, 2026 | 9.592B |
| August 18, 2026 | 9.495B |
| August 17, 2026 | 9.212B |
| August 14, 2026 | 9.126B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 504.75B |
| Incyte Corp. | 23.26B |
| SELLAS Life Sciences Group, Inc. | 2.330B |
| Relay Therapeutics, Inc. | 3.973B |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
Market Cap Related Metrics
| Price to Book Value | 8.332 |
| Price | 90.33 |
| Earnings Yield | -2.41% |